You are viewing a preview of...

Boosting Antiviral Capability of Face Masks

Effectively captures and inactivates specific infectious agents, such as COVID-19 and families of infectious agents, such as influenza

Background

In 2019, an animal coronavirus was believed to have mutated and become infectious towards humans. This novel coronavirus, known as SARS-CoV-2 causes a disease known as coronavirus 2019 (COVID-19). Although work is continuing to definitively understand the modes of virus transmission, mounting evidence suggests that viable virus particles are released into the air from infected hosts when they sneeze, cough, speak or simply breathe. To reduce transmission rates of this potentially fatal virus, public health officials have recommended the use of medical face masks in clinical settings, and non-medical masks by the general public. Recent evidence points to the important role that masks can play in blocking respiratory droplets and aerosol. Mask-use is now either strongly encouraged or mandatory

Log in or create a free account to continue reading